In the test cohort, HOXA5, PTPN2, WT1, HOXD10, POSTN, ADAMDEC1 and MYBPH levels were elevated in glioma tissues with high-risk scores (Figure 6G). The gene discussed is HOXA5; the disease is central nervous system cancer.